Strategic Use of Patent Reissue: Whether and When to Pursue a Reissue Application
Correcting Errors, Responding to an IPR Challenge and Mastering the Recapture Rule
Recording of a 90-minute premium CLE webinar with Q&A
This CLE course will provide patent counsel with an in-depth review of the pros and cons of using reissue, offer their experiences, perspectives and best practices on the strategic use of patent reissue to correct errors.
Outline
- Patent strengthening benefits that reissue can provide against AIA post-grant proceedings before PTAB, as well as district court litigation
- How reissue fits into the big picture of U.S. patent portfolio management in the AIA world
- Prior to or concurrent with PTAB AIA post-grant proceedings, litigation or licensing
- Concurrent reexamination proceeding
- Interferences
- Concurrent litigation and possible stays of reissue
- Concurrent AIA post-grant proceedings and possible stays of reissue
- MPEP rules re: disclosure, concurrent litigation—what about concurrent PTAB proceedings?
- Issues of obviousness-type double patenting (ODP) can be addressed in reissue but currently ODP is not raisable in IPR or PGR
- Comparison of reissue with other tools for correcting patents by patent owners
- Certificate of correction
- Ex parte reexamination
- Supplemental examination under AIA
- Pending U.S. patent applications
Benefits
The panel will review these and other key issues:
- When should counsel be considering the possibility of reissue?
- How have the AIA changes impacted patent reissue?
- What are the risks and limitations of using reissue proceedings to proactively resolve patent validity/unpatentability issues?
- How should counsel try to factor the doctrine of reissue recapture into the decision to file a reissue application?
Faculty
Amelia Feulner Baur, Ph.D
Founding Partner
McNeill Baur
Dr. Baur’s practice covers a broad spectrum of intellectual property issues, including patent preparation and... | Read More
Dr. Baur’s practice covers a broad spectrum of intellectual property issues, including patent preparation and prosecution, coordination of worldwide patent strategies, appeals to the Patent Trial and Appeal Board and the Court of Appeals for the Federal Circuit. She has extensive experience working with clients to develop effective patent strategies to meet business goals. This includes landscape analyses, due diligence investigations, and providing patentability, freedom-to-operate, infringement, and validity opinions. She has also led clients through inter partes review (IPR), reexaminations, interferences, and the settlement of patent disputes.
CloseThomas L. Irving
Partner
Finnegan Henderson Farabow Garrett & Dunner
Mr. Irving has 35 years of experience in the field of IP law. His practice includes due diligence, patent prosecution,... | Read More
Mr. Irving has 35 years of experience in the field of IP law. His practice includes due diligence, patent prosecution, reissue and reexamination, patent interferences, and counseling, including prelitigation, Orange Book listings of patents covering FDA-approved drugs, and infringement and validity analysis in the chemical fields, as well as litigation. Mr. Irving has served as lead counsel in many patent interferences.
CloseJill K. MacAlpine, Ph.D.
Partner
Finnegan Henderson Farabow Garrett & Dunner
Dr. MacAlpine practices patent procurement, due diligence investigations, opinion work, and client counseling,... | Read More
Dr. MacAlpine practices patent procurement, due diligence investigations, opinion work, and client counseling, primarily in the chemical and pharmaceutical areas. She has extensive experience in handling patent matters before the U.S. Patent and Trademark Office (USPTO), including post-grant proceedings specifically IPRs, appeals, and oral hearings at the PTAB; drafting and prosecution of patent applications; reissue and reexamination proceedings; and interferences.
Close